• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃癌中胃微生物群和代谢物的相互作用。

Interactions between gastric microbiota and metabolites in gastric cancer.

机构信息

Jiangxi Otorhinolaryngology Head and Neck Surgery Institute, Department of Otorhinolaryngology Head and Neck Surgery, The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.

Department of Surgical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.

出版信息

Cell Death Dis. 2021 Nov 24;12(12):1104. doi: 10.1038/s41419-021-04396-y.

DOI:10.1038/s41419-021-04396-y
PMID:34819503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8613192/
Abstract

The development and progression of gastric cancer (GC) is greatly influenced by gastric microbiota and their metabolites. Here, we characterized the gastric microbiome and metabolome profiles of 37 GC tumor tissues and matched non-tumor tissues using 16s rRNA gene sequencing and ultrahigh performance liquid chromatography tandem mass spectrometry, respectively. Microbial diversity and richness were higher in GC tumor tissues than in non-tumor tissues. The abundance of Helicobacter was increased in non-tumor tissues, while the abundance of Lactobacillus, Streptococcus, Bacteroides, Prevotella, and 6 additional genera was increased in the tumor tissues. The untargeted metabolome analysis revealed 150 discriminative metabolites, among which the relative abundance of the amino acids, carbohydrates and carbohydrate conjugates, glycerophospholipids, and nucleosides was higher in tumor tissues compared to non-tumor tissues. The targeted metabolome analysis further demonstrated that the combination of 1-methylnicotinamide and N-acetyl-D-glucosamine-6-phosphate could serve as a robust biomarker for distinction between GC tumors and non-tumor tissues. Correlation analysis revealed that Helicobacter and Lactobacillus were negatively and positively correlated with the majority of differential metabolites in the classes of amino acids, carbohydrates, nucleosides, nucleotides, and glycerophospholipids, respectively, suggesting that Helicobacter and Lactobacillus might play a role in degradation and synthesis of the majority of differential metabolites in these classes, respectively. Acinetobacter, Comamonas, Faecalibacterium, Sphingomonas, and Streptococcus were also significantly correlated with many differential amino acids, carbohydrates, nucleosides, nucleotides, and glycerophospholipids. In conclusion, the differences in metabolome profiles between GC tumor and matched non-tumor tissues may be partly due to the collective activities of Helicobacter, Lactobacillus, and other bacteria, which eventually affects GC carcinogenesis and progression.

摘要

胃癌(GC)的发生和发展受胃微生物群及其代谢产物的影响较大。在这里,我们使用 16s rRNA 基因测序和超高效液相色谱串联质谱法分别对 37 个 GC 肿瘤组织和匹配的非肿瘤组织进行了胃微生物组和代谢组特征分析。GC 肿瘤组织中的微生物多样性和丰富度高于非肿瘤组织。非肿瘤组织中 Helicobacter 的丰度增加,而肿瘤组织中 Lactobacillus、Streptococcus、Bacteroides、Prevotella 和其他 6 个属的丰度增加。非靶向代谢组分析显示 150 种有区别的代谢物,其中肿瘤组织中氨基酸、碳水化合物及其糖缀合物、甘油磷脂和核苷的相对丰度高于非肿瘤组织。靶向代谢组分析进一步表明,1-甲基烟酰胺和 N-乙酰-D-葡萄糖胺-6-磷酸的组合可作为区分 GC 肿瘤与非肿瘤组织的有力生物标志物。相关性分析表明,Helicobacter 和 Lactobacillus 分别与氨基酸、碳水化合物、核苷、核苷酸和甘油磷脂等类别的大多数差异代谢物呈负相关和正相关,这表明 Helicobacter 和 Lactobacillus 可能分别在这些类别的大多数差异代谢物的降解和合成中发挥作用。Acinetobacter、Comamonas、Faecalibacterium、Sphingomonas 和 Streptococcus 也与许多差异氨基酸、碳水化合物、核苷、核苷酸和甘油磷脂显著相关。总之,GC 肿瘤组织与匹配的非肿瘤组织之间代谢组谱的差异可能部分归因于 Helicobacter、Lactobacillus 和其他细菌的集体活动,这些活动最终影响 GC 的致癌作用和进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321a/8613192/b54bb5a0acaa/41419_2021_4396_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321a/8613192/b5ed08eb7049/41419_2021_4396_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321a/8613192/b9b678f14f0a/41419_2021_4396_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321a/8613192/dc29f1f1a638/41419_2021_4396_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321a/8613192/2d644bb6ea81/41419_2021_4396_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321a/8613192/b83b3c7cf94f/41419_2021_4396_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321a/8613192/14ed83e96cd1/41419_2021_4396_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321a/8613192/095d738e8231/41419_2021_4396_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321a/8613192/b54bb5a0acaa/41419_2021_4396_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321a/8613192/b5ed08eb7049/41419_2021_4396_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321a/8613192/b9b678f14f0a/41419_2021_4396_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321a/8613192/dc29f1f1a638/41419_2021_4396_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321a/8613192/2d644bb6ea81/41419_2021_4396_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321a/8613192/b83b3c7cf94f/41419_2021_4396_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321a/8613192/14ed83e96cd1/41419_2021_4396_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321a/8613192/095d738e8231/41419_2021_4396_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/321a/8613192/b54bb5a0acaa/41419_2021_4396_Fig8_HTML.jpg

相似文献

1
Interactions between gastric microbiota and metabolites in gastric cancer.胃癌中胃微生物群和代谢物的相互作用。
Cell Death Dis. 2021 Nov 24;12(12):1104. doi: 10.1038/s41419-021-04396-y.
2
Mucosal microbiota characterization in gastric cancer identifies immune-activated-related transcripts relevant gastric microbiome signatures.胃癌黏膜微生物组特征分析鉴定与免疫激活相关的转录本,这些转录本与胃微生物组特征相关。
Front Immunol. 2024 Sep 23;15:1435334. doi: 10.3389/fimmu.2024.1435334. eCollection 2024.
3
Alterations of gastric mucosal microbiota across different stomach microhabitats in a cohort of 276 patients with gastric cancer.276 例胃癌患者不同胃微生境胃黏膜微生物群的改变。
EBioMedicine. 2019 Feb;40:336-348. doi: 10.1016/j.ebiom.2018.12.034. Epub 2018 Dec 21.
4
A Comparison of Tumor-Associated and Non-Tumor-Associated Gastric Microbiota in Gastric Cancer Patients.胃癌患者肿瘤相关与非肿瘤相关胃微生物组的比较。
Dig Dis Sci. 2021 May;66(5):1673-1682. doi: 10.1007/s10620-020-06415-y. Epub 2020 Jun 26.
5
Alterations of thyroid microbiota across different thyroid microhabitats in patients with thyroid carcinoma.甲状腺癌患者不同甲状腺微生境中的甲状腺微生物组改变。
J Transl Med. 2021 Nov 30;19(1):488. doi: 10.1186/s12967-021-03167-9.
6
Microbiota and metabolites alterations in proximal and distal gastric cancer patients.近端胃癌和远端胃癌患者的微生物群和代谢物变化。
J Transl Med. 2022 Sep 30;20(1):439. doi: 10.1186/s12967-022-03650-x.
7
Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.整合微生物组和代谢组分析揭示了共生菌和结直肠癌代谢物之间的新相互作用。
Theranostics. 2019 May 31;9(14):4101-4114. doi: 10.7150/thno.35186. eCollection 2019.
8
Gut microbiota compositional profile and serum metabolic phenotype in patients with primary open-angle glaucoma.原发性开角型青光眼患者的肠道微生物组成特征和血清代谢表型。
Exp Eye Res. 2020 Feb;191:107921. doi: 10.1016/j.exer.2020.107921. Epub 2020 Jan 7.
9
Microbiome changes in the gastric mucosa and gastric juice in different histological stages of -negative gastric cancers.不同组织学阶段 - 阴性胃癌胃黏膜和胃液中的微生物组变化。
World J Gastroenterol. 2022 Jan 21;28(3):365-380. doi: 10.3748/wjg.v28.i3.365.
10
Integrated 16S rRNA Gene Sequencing and LC-MS Analysis Revealed the Interplay Between Gut Microbiota and Plasma Metabolites in Rats With Ischemic Stroke.整合 16S rRNA 基因测序和 LC-MS 分析揭示了缺血性脑卒中大鼠肠道微生物群与血浆代谢物的相互作用。
J Mol Neurosci. 2021 Oct;71(10):2095-2106. doi: 10.1007/s12031-021-01828-4. Epub 2021 May 6.

引用本文的文献

1
Gastrointestinal microbiota in treatment of gastric precancerous lesions and gastric cancer by Western and traditional Chinese medicine.胃肠道微生物群在中西医治疗胃癌前病变和胃癌中的应用
World J Clin Oncol. 2025 Aug 24;16(8):107660. doi: 10.5306/wjco.v16.i8.107660.
2
Infection Drives Glutathione Depletion in Gastric Cancer: Integrated Multi-Omics and Experimental Validation.感染驱动胃癌中的谷胱甘肽耗竭:多组学整合与实验验证
Microorganisms. 2025 Aug 15;13(8):1907. doi: 10.3390/microorganisms13081907.
3
and Gastric Cancer: An Emerging Connection.

本文引用的文献

1
Identification of metabolites associated with prostate cancer risk: a nested case-control study with long follow-up in the Northern Sweden Health and Disease Study.与前列腺癌风险相关代谢物的鉴定:在瑞典北部健康与疾病研究中进行的一项具有长期随访的巢式病例对照研究。
BMC Med. 2020 Jul 23;18(1):187. doi: 10.1186/s12916-020-01655-1.
2
Decreased Mitochondrial DNA Content Drives OXPHOS Dysregulation in Chromophobe Renal Cell Carcinoma.线粒体 DNA 含量降低导致嫌色细胞肾细胞癌 OXPHOS 失调。
Cancer Res. 2020 Sep 15;80(18):3830-3840. doi: 10.1158/0008-5472.CAN-20-0754. Epub 2020 Jul 21.
3
Metabolomic profiling of gastric cancer tissues identified potential biomarkers for predicting peritoneal recurrence.
与胃癌:一种新出现的联系。
Int J Mol Sci. 2025 Aug 16;26(16):7915. doi: 10.3390/ijms26167915.
4
Microbiome in Neuroblastoma: A Virgin Island in the World of Onco-Microbiome.神经母细胞瘤中的微生物组:肿瘤微生物组领域的一片处女地。
Cells. 2025 Aug 7;14(15):1218. doi: 10.3390/cells14151218.
5
Gut microbiome and gastric cancer: microbial interactions and therapeutic potential.肠道微生物群与胃癌:微生物相互作用及治疗潜力
Gut Pathog. 2025 Jul 26;17(1):56. doi: 10.1186/s13099-025-00729-w.
6
The tumor microbiome in cancer progression: mechanisms and therapeutic potential.癌症进展中的肿瘤微生物群:机制与治疗潜力
Mol Cancer. 2025 Jul 15;24(1):195. doi: 10.1186/s12943-025-02403-w.
7
Microbiota and gastric cancer: from molecular mechanisms to therapeutic strategies.微生物群与胃癌:从分子机制到治疗策略
Front Cell Infect Microbiol. 2025 Jun 3;15:1563061. doi: 10.3389/fcimb.2025.1563061. eCollection 2025.
8
Crosstalk between metabolic reprogramming and microbiota: implications for cancer progression and novel therapeutic opportunities.代谢重编程与微生物群之间的串扰:对癌症进展和新型治疗机会的影响
Front Immunol. 2025 May 20;16:1582166. doi: 10.3389/fimmu.2025.1582166. eCollection 2025.
9
Harnessing technologies to unravel gastric cancer heterogeneity.利用技术揭示胃癌异质性。
Trends Cancer. 2025 Aug;11(8):753-769. doi: 10.1016/j.trecan.2025.04.011. Epub 2025 May 27.
10
Esophageal cancer and precancerous lesions: focus on resident bacteria and fungi.食管癌与癌前病变:聚焦于常驻细菌和真菌。
Microbiol Spectr. 2025 Jul;13(7):e0313724. doi: 10.1128/spectrum.03137-24. Epub 2025 May 20.
胃癌组织的代谢组学分析确定了预测腹膜复发的潜在生物标志物。
Gastric Cancer. 2020 Sep;23(5):874-883. doi: 10.1007/s10120-020-01065-5. Epub 2020 Mar 26.
4
Gastric mucosal microbiota in a Mongolian population with gastric cancer and precursor conditions.患有胃癌及癌前病变的蒙古族人群的胃黏膜微生物群
Aliment Pharmacol Ther. 2020 Apr;51(8):770-780. doi: 10.1111/apt.15675. Epub 2020 Mar 4.
5
Influence of gastrectomy for gastric cancer treatment on faecal microbiome and metabolome profiles.胃癌治疗性胃切除术后粪便微生物组和代谢组特征的影响。
Gut. 2020 Aug;69(8):1404-1415. doi: 10.1136/gutjnl-2019-319188. Epub 2020 Jan 16.
6
Adenosine Metabolism: Emerging Concepts for Cancer Therapy.腺苷代谢:癌症治疗的新兴概念。
Cancer Cell. 2019 Dec 9;36(6):582-596. doi: 10.1016/j.ccell.2019.10.007.
7
Microbial characterization of esophageal squamous cell carcinoma and gastric cardia adenocarcinoma from a high-risk region of China.中国高危地区食管鳞癌和贲门腺癌的微生物特征。
Cancer. 2019 Nov 15;125(22):3993-4002. doi: 10.1002/cncr.32403. Epub 2019 Jul 29.
8
Alterations of gastric mucosal microbiota across different stomach microhabitats in a cohort of 276 patients with gastric cancer.276 例胃癌患者不同胃微生境胃黏膜微生物群的改变。
EBioMedicine. 2019 Feb;40:336-348. doi: 10.1016/j.ebiom.2018.12.034. Epub 2018 Dec 21.
9
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
10
Airway Microbiota Is Associated with Upregulation of the PI3K Pathway in Lung Cancer.气道微生物群与肺癌中 PI3K 通路的上调有关。
Am J Respir Crit Care Med. 2018 Nov 1;198(9):1188-1198. doi: 10.1164/rccm.201710-2118OC.